- Home
- TACT vs SRZN Comparison
TACT vs SRZN Comparison
Compare TACT & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TACT
- SRZN
- Stock Information
- Founded
- TACT 1996
- SRZN 2015
- Country
- TACT United States
- SRZN United States
- Employees
- TACT N/A
- SRZN N/A
- Industry
- TACT Computer peripheral equipment
- SRZN Medicinal Chemicals and Botanical Products
- Sector
- TACT Technology
- SRZN Health Care
- Exchange
- TACT Nasdaq
- SRZN Nasdaq
- Market Cap
- TACT 40.4M
- SRZN 38.1M
- IPO Year
- TACT 1996
- SRZN N/A
- Fundamental
- Price
- TACT $3.93
- SRZN $9.18
- Analyst Decision
- TACT Strong Buy
- SRZN
- Analyst Count
- TACT 1
- SRZN 0
- Target Price
- TACT $7.50
- SRZN N/A
- AVG Volume (30 Days)
- TACT 24.3K
- SRZN 33.9K
- Earning Date
- TACT 11-07-2024
- SRZN 11-06-2024
- Dividend Yield
- TACT N/A
- SRZN N/A
- EPS Growth
- TACT N/A
- SRZN N/A
- EPS
- TACT N/A
- SRZN N/A
- Revenue
- TACT $46,418,000.00
- SRZN $10,000,000.00
- Revenue This Year
- TACT N/A
- SRZN N/A
- Revenue Next Year
- TACT $22.65
- SRZN N/A
- P/E Ratio
- TACT N/A
- SRZN N/A
- Revenue Growth
- TACT N/A
- SRZN N/A
- 52 Week Low
- TACT $3.32
- SRZN $6.00
- 52 Week High
- TACT $7.97
- SRZN $16.19
- Technical
- Relative Strength Index (RSI)
- TACT 39.62
- SRZN 45.92
- Support Level
- TACT $3.81
- SRZN $8.10
- Resistance Level
- TACT $4.14
- SRZN $10.76
- Average True Range (ATR)
- TACT 0.18
- SRZN 1.25
- MACD
- TACT -0.01
- SRZN -0.16
- Stochastic Oscillator
- TACT 26.85
- SRZN 22.90
About TACT TransAct Technologies Incorporated
Transact Technologies Inc develops and sells software-driven technology and printing solutions. The company's software is sold under BOHA, AccuDate, Epic, EPICENTRAL, Ithaca, and Printrex brand names. It also provides supplies and consumables used in the printing and scanning activities to restaurant and hospitality, banking, retail, casino and gaming, point of sale automation, lottery, medical, mobile, oil, and gas markets. Majority of the revenue is derived from the casinos and gaming industry followed by the Foodservice technology market. Its geographical segments are the United States and International, of which the majority of its revenue comes from the United States.
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).